Uganda's Middle-Income Ambitions Tested by Pharmaceutical Access Concerns

Uganda’s pursuit of middle-income status is facing scrutiny regarding its readiness to sustain economic progress, particularly in critical sectors like healthcare. A recent report highlights that upon graduating from Least Developed Country (LDC) status, Uganda may lose access to crucial flexibilities that currently allow it to import or produce generic versions of patented medicines at lower costs.

This transition means Uganda will no longer benefit from the blanket LDC waiver. Instead, it will have to rely on more complex TRIPS flexibilities, which require greater administrative capacity and could be subject to political pressure. This shift could significantly impact public procurement, domestic pharmaceutical manufacturing, and national intellectual property enforcement.

Researchers warn that essential medicines for conditions such as HIV/AIDS, tuberculosis, and non-communicable diseases, including cancer drugs and insulin, could become substantially more expensive. For instance, a dose of lenacapavir, currently accessible through subsidized programs for $20-$40, could incur much higher commercial prices post-graduation.

Uganda has met some criteria for LDC graduation, with a potential formal exit from the LDC category as early as 2030 or 2032. However, experts emphasize that the transition should not just be about prestige but about building sufficient domestic capacity to become self-sustaining.

The report recommends that Uganda implement transitional safeguards and policy measures before losing LDC-specific intellectual property exemptions. Strengthening local pharmaceutical manufacturing, enhancing the use of existing intellectual property flexibilities, and investing in domestic capacity are crucial steps to mitigate potential risks and ensure continued access to affordable medicines. The government’s ambition for middle-income status must be accompanied by robust strategies to protect the progress made in healthcare access.

This report was reviewed in Kampala on Friday, September 19, 2026. Source: Daily Monitor (Uganda).